Regulatory Approval for Drugs, Medical Devices, Cosmetics & Diagnostics
CDSCO Registration is a mandatory regulatory requirement for companies involved in the manufacture, import, sale, or distribution of pharmaceuticals, medical devices, cosmetics, and diagnostic products in India.
The Central Drugs Standard Control Organisation (CDSCO) functions under the Directorate General of Health Services (DGHS), Ministry of Health & Family Welfare, Government of India, and acts as the National Regulatory Authority (NRA).
CDSCO operates under:
The primary objective of CDSCO is to ensure that products entering the Indian market are safe, effective, and compliant with applicable quality standards.
CDSCO Registration is the process through which drugs, medical devices, cosmetics, and diagnostics are evaluated and approved for marketing in India. This process ensures:
Without CDSCO approval, no regulated product can be legally sold or distributed in India.
If you are a manufacturer or importer intending to introduce regulated products in India, CDSCO registration is compulsory.
CDSCO operates through:
Head Office: FDA Bhawan, Kotla Road, New Delhi – 110002
The CDSCO registration process is conducted primarily through the SUGAM online portal and follows a structured regulatory review mechanism.
The approval timeline depends on:
CDSCO may suspend or cancel registration due to:
After registration, manufacturers must comply with:
CDSCO provides approvals under multiple categories:
Required for pharmaceutical substances not previously approved in India, including:
Mandatory for importing:
Required for Indian manufacturers producing regulated products
Applicable for both imported and domestically manufactured devices Risk-based classification:
Mandatory for import or manufacture of cosmetic products
Required for conducting clinical trials in India
Technical assessment of regulatory dossiers before approval
Required for exporting regulated products to global markets
CDSCO operates under:
Data accuracy is critical. Any misleading or false information may result in rejection or cancellation.
Qualitance India provides end-to-end CDSCO consultancy services, helping manufacturers and importers navigate India’s complex regulatory framework smoothly.
We focus on regulatory accuracy, documentation precision, and faster approvals.
Central Drugs Standard Control Organisation.
Manufacturers, importers, and authorized representatives of regulated products.
Yes, in most cases, especially for Class B, C, and D devices.
Products must be withdrawn from the market until renewal.
It ensures ongoing product safety after market launch.
CDSCO Registration is a critical regulatory milestone for entering and operating in the Indian healthcare and pharmaceutical market. Proper compliance not only ensures legal market access but also builds trust, safety, and credibility.
With expert guidance, the CDSCO process becomes structured, predictable, and compliant.
Email: info@qualitanceindia.com
Delhi | PAN-India & International Regulatory Support